SimplicityBio SA

SimplicityBio is a pioneering biomarker discovery company operating in the molecular diagnostic sector, with a strong focus on offering robust, multi-biomarker solutions to its clients. Since its establishment in 2013 by Matthew Hall, Pedro Faustino, and Miguel Barreto, the company has been committed to delivering reliable biomarker services and products, including biomarker discovery and ranking, signature creation, and enhancement of existing signatures. The company's services span a broad spectrum, catering to the needs of clients in the biotechnology and pharmaceutical industries. SimplicityBio also focuses on the development of scientific innovations, intellectual property, and white paper technologies for its clients. The company operates out of Monthey. On May 19, 2016, SimplicityBio secured a Non-Equity Assistance investment from MassChallenge. This investment stands as a testament to the company's potential and the confidence of investors in its mission and capabilities. With its vision of emerging as a top-tier biomarker discovery company, SimplicityBio continues to make strides in advancing molecular diagnostics and offering innovative solutions to its clients.